[Journal logo]

Volume 66 
Part 4 
Page o952  
April 2010  

Received 15 March 2010
Accepted 20 March 2010
Online 27 March 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.002 Å
R = 0.040
wR = 0.119
Data-to-parameter ratio = 17.6
Details
Open access

4-Hydroxy-3-(1'-methyl-2-oxo-4'-phenylspiro[indoline-3,2'-pyrrolidine]-3'-ylcarbonyl)quinolin-2(1H)-one

aCentre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600 025, India, and bDepartment of Chemistry, School of Chemical Sciences, Bharathiar University, Coimbatore 641 046, India
Correspondence e-mail: mnpsy2004@yahoo.com

In the title compound, C28H23N3O4, the dihedral angle between the quinoline and indole ring systems is 29.30 (5)°. The pyrrolidine ring adopts a twist conformation. An intramolecular O-H...O hydrogen bond generates an S(6) ring motif. A weak intramolecular C3-H3...O3 interaction is also observed. In the crystal, molecules are linked by two sets of N-H...O hydrogen bonds, forming centrosymmetric dimers containing two R22(8) ring motifs. The dimers are linked via C-H...[pi] interactions.

Related literature

For general background to indole, quinoline and pyrrolidine derivatives, see: Amalraj et al. (2003[Amalraj, A., Raghunathan, R., Sridevi Kumari, M. R. & Raman, N. (2003). Bioorg. Med. Chem. 11, 407-419.]); Cordell (1981[Cordell, G. (1981). Introduction to Alkaloids: A Biogenic Approach. New York: Wiley International.]); Suzuki et al. (1994[Suzuki, H., Aoyagi, S. & Kibayashi, C. (1994). Tetrahedron Lett. 35, 6119-6122.]). For puckering parameters, see: Cremer & Pople (1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]). For asymmetry parameters, see: Nardelli (1983[Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.]). For hydrogen-bond motifs, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]).

[Scheme 1]

Experimental

Crystal data
  • C28H23N3O4

  • Mr = 465.49

  • Triclinic, [P \overline 1]

  • a = 9.6918 (3) Å

  • b = 11.0258 (3) Å

  • c = 12.9663 (4) Å

  • [alpha] = 69.111 (1)°

  • [beta] = 72.044 (2)°

  • [gamma] = 66.410 (1)°

  • V = 1163.93 (6) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.09 mm-1

  • T = 293 K

  • 0.20 × 0.20 × 0.20 mm

Data collection
  • Bruker SMART APEXII area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.982, Tmax = 0.982

  • 21655 measured reflections

  • 5795 independent reflections

  • 4635 reflections with I > 2[sigma](I)

  • Rint = 0.023

Refinement
  • R[F2 > 2[sigma](F2)] = 0.040

  • wR(F2) = 0.119

  • S = 1.03

  • 5795 reflections

  • 329 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.22 e Å-3

  • [Delta][rho]min = -0.19 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg6 is the centroid of the C26-C31 ring.

D-H...A D-H H...A D...A D-H...A
O4-H4A...O2 0.99 (2) 1.56 (2) 2.4840 (14) 155 (2)
N8-H8...O3i 0.89 (2) 1.92 (2) 2.7837 (13) 165 (2)
N18-H18...O1i 0.90 (2) 1.95 (2) 2.8497 (14) 177 (2)
C3-H3...O3 0.98 2.21 2.7944 (13) 117
C21-H21...Cg6ii 0.93 2.72 3.5360 (18) 147
Symmetry codes: (i) -x, -y+2, -z; (ii) -x+1, -y+2, -z.

Data collection: APEX2 (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI5061 ).


References

Amalraj, A., Raghunathan, R., Sridevi Kumari, M. R. & Raman, N. (2003). Bioorg. Med. Chem. 11, 407-419.  [PubMed]
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.  [CrossRef] [ChemPort] [ISI]
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cordell, G. (1981). Introduction to Alkaloids: A Biogenic Approach. New York: Wiley International.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.  [CrossRef] [ChemPort] [ISI]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.  [CrossRef] [details]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Suzuki, H., Aoyagi, S. & Kibayashi, C. (1994). Tetrahedron Lett. 35, 6119-6122.  [CrossRef] [ChemPort] [ISI]


Acta Cryst (2010). E66, o952  [ doi:10.1107/S1600536810010500 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.